 Clinical Oncology News | Spotlight on selected articles from the Journal of Clinical Oncology and Blood Clinical Oncology News Anas Younes, MD; Yvette Kasamon, MD; and colleagues took advantage of the CD-20 expression in classical Hodgkin's lymphoma (cHL) and presented Phase III data adding rituximab to ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) in patients ... |
